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Background: Proximal femoral fracture is a common, major health problem in old age resulting in loss of functional
independence and a high-cost burden on society, with estimated health and social care costs of £2.3 billion per year in
the UK. Rehabilitation has the potential to maximise functional recovery and maintain independent living, but evidence
of effectiveness is lacking. Usual rehabilitation care is delivered by a multi-disciplinary team in the hospital and in the
community. An ‘enhanced rehabilitation’ intervention has been developed consisting of a workbook, goal-setting diary
and extra therapy sessions, designed to improve self-efficacy and increase the amount and quality of the practice of
physical exercise and activities of daily living.
Methods/design: This paper describes the design of a phase II study comprising an anonymous cohort of all proximal
femoral fracture patients admitted to the three acute hospitals in Betsi Cadwaladr University Health Board over a 6-month
period with a randomised feasibility study comparing the enhanced rehabilitation intervention with usual care.
These will assess the feasibility of a future definitive randomised controlled trial and concurrent economic evaluation in
terms of recruitment, retention, outcome measure completion, compliance with the intervention and fidelity of
delivery, health service use data, willingness to be randomised and effect size for a future sample size calculation.
Focus groups will provide qualitative data to contribute to the assessment of the acceptability of the intervention
amongst patients, carers and rehabilitation professionals and the feasibility of delivering the planned intervention.
The primary outcome measure is function assessed by the Barthel Index. Secondary outcomes measure the ability
to perform activities of daily living, anxiety and depression, potential mediators of outcomes such as hip pain,
self-efficacy and fear of falling, health utility, health service use, objectively assessed physical function and adverse
events. Participants’ preference for rehabilitation services will be assessed in a discrete choice experiment.
Discussion: Phase II studies are an opportunity to not only assess the feasibility of trial methods but also to
compare different methods of outcome measurement and novel methods of obtaining health service use data
from routinely collected patient information.
(Continued on next page)* Correspondence: nefyn.williams@bangor.ac.uk
1Schools of Medical and Healthcare Sciences, Bangor University, Bangor, UK
3Betsi Cadwaladr University Health Board, North Wales, UK
Full list of author information is available at the end of the article
© 2015 Williams et al.; licensee BioMed Central. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Williams et al. Pilot and Feasibility Studies  (2015) 1:13 Page 2 of 22(Continued from previous page)
Trial registration: Current Controlled Trials ISRCTN22464643, UKCRN16677.
Keywords: Proximal femoral fracture, Rehabilitation, Self-efficacy, Randomised controlled trial, Cohort, Focus
group, Acceptability, Feasibility, Discrete choice experiment, Economic evaluationBackground
Proximal femoral fracture, more commonly referred to
as hip fracture, is a common, major health problem in
old age [1], and as the population ages, the number of
elderly people falling and fracturing their hips is pro-
jected to increase further. Occurrence of hip fracture is
strongly associated with decreased bone mineral density,
increased age, prior fragility fracture, low muscular
strength levels, cognitive impairment, chronic disease,
under-nutrition, frailty, poor physical functioning, vision
problems and weight loss (especially muscle loss) [2].
Mortality is high with 25% dying within the following 12
months. A review of the long-term disability associated
with proximal femoral fracture found that 29% of pa-
tients did not regain their pre-fracture level of function-
ing after 1 year in terms of restrictions of activities of
daily living [3]. Many people who were living independ-
ently before their fracture lose their independence after-
wards, so it imposes a large health and social care cost
burden on society amounting to £2.3 billion a year in
the UK, equating to approximately £6 million a day [4].
Tian et al. [5] explored Torbay’s (Devon) unique patient-
level linked data set of National Health Service (NHS)
and social care costs for older people in the 12 months
before and after being admitted to hospital as a result of
a fall. They found that the cost of hospital, community
and social care cost services for each patient were almost
four times as costly in the 12 months after admission,
compared to the costs of the admission itself, and that
the majority of costs occurred outside of the acute hos-
pital setting. Particularly frail individuals may go onto
have a further proximal femoral fracture resulting in
additional disability and deaths [6].
Three phases of recovery from proximal femoral frac-
ture have been described and are useful for research pur-
poses [7]. The first phase is in the hospital, recovering
from injury and surgery, and making safe to discharge.
The second phase is rehabilitation either in an institu-
tion or at home. The final phase is the enduring stage
where patients use their own previous health belief strat-
egies to determine if and when they have recovered. The
National Institute for Health and Care Excellence
(NICE) has issued guidelines for the management of hip
fracture [8]. As well as prompt surgical treatment, the
guidelines recommend that the associated medical needs
are assessed promptly by a physician specialised in car-
ing for this patient group, who can also identify goals fora programme of multidisciplinary rehabilitation. Such re-
habilitation starts whilst in hospital during post-operative
recovery and continues in the community following hos-
pital discharge. It is delivered by a multidisciplinary team
depending upon patients’ individual needs at different
times during their recovery and on the availability and ac-
cessibility of services in different areas. Rehabilitation has
the potential to maximise recovery, enhance quality of life
and maintain independence, but whilst individual compo-
nents of such programmes show promise, there is insuffi-
cient evidence of overall effectiveness or cost-effectiveness
or of processes of change and potential psychological me-
diators [9-13]. The aim of our study is to finalise a new re-
habilitation intervention and to complete a feasibility study
before a definitive randomised controlled trial (RCT). The
design of the feasibility study is described here.
Developing a rehabilitation intervention
We have completed the first phase of this research project
to develop a new multidisciplinary rehabilitation interven-
tion within the Medical Research Council’s (MRC) frame-
work for complex intervention development [14]. This
was informed by a realist review [15,16] of the rehabilita-
tion literature, which differs from a traditional systematic
review [17] in that it utilises a theory-driven approach and
attempts to combine principles of conventional reviews as
well as a philosophy of realism, thus adopting an explana-
tory rather than a judgemental approach to evidence syn-
thesis [16]. It does not provide simple answers to complex
problems but rather provides a flexible way of building an
explanatory account of what works for whom under what
circumstances, taking into account the heterogeneous na-
ture of complex programmes or interventions [17,18].
Hence, we used this approach to determine the mecha-
nisms behind multidisciplinary rehabilitation and to estab-
lish which components were effective (or not effective) for
specific patient groups and in which circumstances [16].
In addition, we carried out a survey of current rehabilita-
tion practice in the United Kingdom and focus groups of
members of multidisciplinary teams and hip fracture pa-
tients to obtain their views about current rehabilitation
programmes.
Mechanisms which the realist review highlighted as
being important for successful outcomes included the
following: tailoring the intervention to the patient; the
regular practice of physical activities and activities of
daily living; enhancement of psychological beliefs about
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ership to engage in exercise; and co-ordinated provision of
the multidisciplinary rehabilitation programme.Study objectives
The objectives of this study are the following:
1) To assess the acceptability of, and compliance with,
the rehabilitation programme amongst patients,
carers and clinicians and the fidelity of its delivery
and to identify any adverse events.
2) To assess the feasibility of a future definitive RCT by
assessing the number of eligible patients, monitoring
recruitment and retention rates, exploring the
willingness of patient participants to be randomised
and the willingness of patients and carers to
complete process and outcome measures.
3) To produce means and standard deviations of the
quantitative measures so that effect sizes can be
calculated for planning the future RCT.
4) To explore how the intervention creates change in
self-efficacy and fear of falling as potential mediators
for improving function.
5) To explore the methodological issues for conducting
an economic evaluation alongside a future RCT
including identifying the most efficient way of
measuring patient level costs and health benefits,
programme costs and potential payer stakeholders.
6) To explore the feasibility and quality of data on
service use extracted from patient electronic records
compared with patient reported outcome measures.
If successful, replacing patient reported outcomes of
service use with data collection by researchers and
the NHS information technology (IT) staff for
electronic records has potential to reduce
participant burden in future studies (this is referred
to as the triangulation study later in the paper).Methods/design
Study design
Phase II comprises the second stage of the MRC frame-
work for assessing complex interventions [14]. It will con-
sist of an anonymous cohort study of all proximal femoral
fracture patients (Figure 1) with an embedded randomised
feasibility study (Figures 2 and 3) to achieve the objectives
stated earlier. The acceptability and feasibility of the new
rehabilitation programme will be assessed with further
focus groups of the multi-disciplinary rehabilitation teams,
hip fracture patients and their carers. The role of behav-
ioural cognitions will be examined as process measures. It
will also contain a sub-study to explore the potential for
collecting health resource use from routinely collected
electronic patient records.Cohort study
Selection of subjects for cohort study
The cohort will consist of an anonymised data set of all pa-
tients 65 years of age and over admitted to the three main
acute hospitals of Betsi Cadwaladr University Health Board
(BCUHB) in North Wales (Wrexham Maelor, Ysbyty Glan
Clwyd and Ysbyty Gwynedd) with hip fracture during the
first 6 months of the study period; who will subsequently
be followed up for 3 months. BCUHB is the largest health
board in Wales with a population of 692,000. Data col-
lected will include type of fracture, type of surgery, length
of stay in acute hospital, serious complications, mortality
rates, repeat fractures, place of residence on admission,
place of discharge from acute and community hospitals
and serious illnesses requiring hospital re-admission. Audit
figures returned to the National Hip Fracture Database
give a conservative estimate that approximately 100 to 180
patients are admitted to each of these hospitals (a total of
300 to 540) in a 6-month period [19].
Cohort study outcomes
From the cohort anonymised data set, we will record the
following:
 The number of patients aged over 65 years admitted
with a proximal femoral fracture.
 The number of patients who fulfil the inclusion
criteria for the randomised feasibility study.
 The number of deaths, serious complications such
as falls and repeat fractures, serious illness requiring
hospital re-admission and discharged to institutional
care. This will include details such as the type of
ward and the type of residential care in order to
calculate the cost per night locally. This will be
compared with the Department of Health reference
costs for proximal femoral fracture related hospital
stays.
Randomised feasibility study
Selection of subjects for randomised feasibility study
Of all those admitted, we anticipate that we will be able
to identify and invite 150 patients (50% of a conservative
estimate of the total) from the three hospital sites across
BCUHB during the 6-month study period to participate
in the embedded feasibility study comparing usual care
with the enhanced rehabilitation package using a rando-
mised design. We will attempt to recruit 50 patients to
this randomised feasibility study. The number of eligible
patients, the recruitment and retention rates and the num-
ber who completed the outcome questionnaires will be re-
corded. It will be important to determine whether random
allocation to either intervention arm is acceptable to pa-
tients, carers and clinicians providing the service. The
feasibility study will also be an opportunity to test a
All patients admitted to the study site 
acute hospitals (N=3) for six months
with fractured neck of femur
Cohort
Participants meeting inclusion criteria identified and anonymised data 
extracted from notes 
Inclusion criteria: 
Aged 65+
Surgical repair of fractured neck of femur 
Data will collected for 3 months follow up after fracture and will 
include:
type of fracture, 
type of surgery, 
length of stay in acute hospital, 
serious complications, 
mortality rates
repeat fractures, 
place of residence on admission, 
place of discharge from acute and community hospitals, 
serious illnesses requiring hospital re-admission
Figure 1 Cohort participant flow diagram.
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nomic measures, for the main trial and to inform the ef-
fect size for a future sample size calculation. These
patients will also be recruited to a triangulation study
which aims to compare the quality of data collected about
service use from patient-reported outcome measures com-
pared with extracting the same information from patient
electronic records.
Inclusion criteria for patient participants to feasibility study
We will aim to recruit older adults recovering on an
orthopaedic ward with proximal femoral fracture who
were previously living independently and who have re-
cently received surgical treatment. The specific inclusion
criteria are as follows:
 Age 65 years or older;
 Recent proximal hip fracture including the following
types of fracture: intracapsular, extracapsular(pertrochanteric, intertrochanteric, reverse oblique
or subtrochanteric);
 Surgical repair by replacement arthroplasty or
internal fixation;
 Recovering as an in-patient on an orthopaedic ward,
transferred to an in-patient rehabilitation ward or
who have been discharged home;
 Living in their own home prior to hip fracture;
 Capacity to give informed consent; and
 Living and receiving rehabilitation from the NHS in
the area covered by BCUHB.
Exclusion criteria
The exclusion criteria are as follows:
 Living in residential or nursing homes prior to hip
fracture; and
 Participants who are not able to understand Welsh
or English.
Identification of patients and screening
Recruitment to randomised feasibility 
study n>50
Intervention–enhanced  
rehabilitation 
n>25
Control - usual care
N>25
Baseline measurement
3 month follow up–measures 3 month follow up
Focus groups 
3 x patient/carer
3 x professionals
n= 6 to 8 participants per group
Remote randomisation
All patients admitted to the study site 
acute hospitals (n=3) for nine months
with fractured neck of femur
Figure 2 Randomised feasibility study participant flow diagram.
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Clinical staff on the orthopaedic wards of the three main
hospitals in BCUHB will screen patients for eligibility. If
eligible, the clinicians will approach the potential partici-
pant to see if they would be interested in taking part and
willing to be seen by a researcher. The study team re-
searchers supported by National Institute for Social care
and Health Research (NISCHR) Clinical Research Centre
(CRC) research professionals will then recruit patients
following the study’s informed consent process which
has been reviewed and approved by the NHS research
ethics committee (see Additional files 1 and 2).
It is possible that during the study some participants’
capacity may change. Consequently, at follow-up, the re-
searcher will be asked to assess whether the participantno longer has capacity to give informed consent when
arranging the follow-up visit. If the patient no longer has
capacity, no follow-up data will be collected, but the
baseline and any other data collected to this point will
be used in the analysis.
The study is taking place in an area where there are
two official national languages, Welsh and English. Con-
sequently, participants will be given a choice of Welsh
or English language patient information sheets and in-
formed consent forms. Where validated outcome mea-
sures exist in the Welsh language, participants will have
the option to complete them in that language.
The researcher will complete the outcome measures
with the patient participant before randomisation. The pa-
tients’ general practitioner and treating consultants will be
Figure 3 Randomised feasibility study recruitment process flow diagram.
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medical records.
Informed consent - carer participants
Carers for the purpose of this study are defined as people
caring for a hip fracture patient recruited to the study by
providing them with face to face support most days in a
week including help with activities of daily living and/or
physical care. They may be a relative or a friend. The study
team researchers supported by the NISCHR CRC research
professionals will identify and recruit carers following the
study’s informed consent process (similar to Additional
files 1 and 2). Carers will be asked to complete a carer
burden questionnaire [20] at baseline and at follow-up.
Randomisation
Patient participants who give their informed consent will
complete baseline process and outcome measures before
being individually randomised. The randomisation will be
performed by dynamic allocation [21] to protect against
subversion whilst ensuring that the trial maintains good
balance to the allocation ratio of 1:1 both within each
stratification variable and across the trial. Participants will
be stratified by: (1) hospital and (2) gender.
Randomisation will be requested by the researcher who
has taken informed consent and will be achieved by secure
web access to the remote randomisation centre at the
North Wales Organisation for Randomisation Trials in
Health (NWORTH), Bangor University. This system will
be set up, maintained and monitored independently of the
trial statistician or other trial staff. The randomisation pro-
cedures will be aligned with NWORTH standard operating
procedure 5.01 to ensure best practice. The key to the ran-
domisation code will be held centrally by NWORTH.
Blinding
Collection of outcome measures, including physical
function measures, and data analysis will be performed
blind to treatment allocation. This is a pragmatic study
comparing two rehabilitation interventions, so it will not
be possible to blind participants or their clinicians to
treatment group allocation.
Withdrawal of participants
Participant withdrawal from the study will not affect their
medical or social care, and this point will be emphasised
in the patient information sheet and during the informed
consent process. Similarly, withdrawal of carer partici-
pants will not affect the medical or social care of the hip
fracture patient they are caring for.
Non-completion of the follow-up questionnaires or phys-
ical function tests will not constitute formal withdrawal
from the trial, and unless the participant requests with-
drawal of their data completely, it may be used to imputevalues for the analysis. The imputation of missing values
will ensure that the dataset is utilised to its full power.
Expected duration of feasibility study
Participants will be recruited over a 9-month period and
followed-up for 3 months.
Interventions
An ‘enhanced rehabilitation’ intervention will be com-
pared with usual rehabilitation care. Usual care consists
of a multi-disciplinary rehabilitation delivered by the
acute hospital, community hospital and community ser-
vices depending on patients’ individual needs at different
times during their recovery and on the availability and
accessibility of services in different areas. The multidis-
ciplinary team delivering care and rehabilitation includes
orthopaedic surgeons, orthogeriatricians, nurses, physio-
therapists, occupational therapists, dieticians, pharma-
cists, general practitioners (GPs) and social workers. The
settings for care include acute orthopaedic or orthogeria-
tric wards, rehabilitation units in community hospitals, re-
habilitation beds in care homes, the patient’s own home
and care home settings all delivered by a variety of com-
munity teams in both health and social care services.
The main aim of the intervention is to enhance usual
rehabilitation by increasing the amount and quality of
patients’ practice of physical exercise and activities of
daily living in order to improve their functional out-
comes at the 3-month follow up. We also hypothesise
that improving patients’ self-efficacy will increase their
motivation to engage in the rehabilitation process, im-
prove the quality and quantity of this practice and in-
crease their engagement.
We will endeavour to enhance rehabilitation self-
efficacy [22] by means of a patient-held information work-
book and goal-setting diary given to the participant in the
acute hospital which they will keep throughout the follow-
up period of the study. Six additional therapist/technical
instructor sessions will be available to patients once they
return home or are admitted permanently to a care home.
These extra sessions will be tailored to individuals’
needs at the discretion of the community occupational
therapist or physiotherapist responsible for their care in
liaison with the therapists allocated to deliver the extra
sessions.
The objectives of the workbook and goal-setting diary
are as follows:
1) To give patients better understanding of what has
happened physically to them and broadly what to
expect during their recovery;
2) To provide information and contact details on
rehabilitation services that may be available to
them as they progress in their rehabilitation (e.g.
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teams, outpatient physiotherapy, falls prevention
groups, national exercise referral services);
3) To enable them to work collaboratively with their
therapist to set realistic goals and monitor progress
of their rehabilitation in order to improve the
quality and the quantity of the physical and activities
of daily living exercises they are given;
4) To improve patients’ self-efficacy by the following:
a. Encouraging the patient to set mobility
and activities of daily living goals that they
want to achieve and to discuss what might
facilitate or impede their attainment with their
therapist.
b. Monitoring these goals by keeping a diary of
progress made, which will provide feedback in
the form of self-reflection and reflection with
the therapist, highlighting success and mastery
that is known to be important for improving
self-efficacy [23].Figure 4 Logic model of enhanced rehabilitation intervention followi5) To improve communication between hospital and
community services and between the patient and all
the different professionals and services they come
into contact with during their rehabilitation;
6) To reduce patients’ fear of falling by improving
self-efficacy for avoiding falls and exercising; and
7) To signpost patients to local follow-on community
programmes such as exercise referral and falls
prevention services with contact details.
A logic model has been developed which describes
how the study team has linked the programme theories
from the realist review with the components of the
intervention, the short-and long-term goals of the inter-
vention, and functional outcomes in terms of the In-
ternational Classification of Functioning, Disability and
Health (ICF) [24] (Figure 4). We have also mapped the
intervention components to the NICE recommendations
for the multidisciplinary rehabilitation of hip fracture [8]
(Figure 5). Therapists in BCUHB have contributed tong proximal femoral fracture.
Figure 5 Mapping the rehabilitation intervention to the NICE recommendations for the management of hip fracture.
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particular, commenting on usability, accuracy and local
information issues.
Delivery of the intervention
The intervention will be delivered by the therapists and
their assistant staff employed by BCUHB. The therapy
service managers in BCUHB have agreed to organise the
extra sessions for patients in the intervention arm of the
study, which will be funded by NHS excess treatment
costs. The extra six sessions of rehabilitation will be
delivered by additional physiotherapists and therapy as-
sistants. This will be done in collaboration with the
existing therapists delivering the usual care. The inter-
vention therapy teams will be alerted to which group the
patient is randomised and will arrange a time for an ini-
tial assessment and goal-setting session to visit the pa-
tient in the acute hospital or in a community setting.
The remaining five sessions will be used according to in-
dividual’s need and the individual’s rehabilitation plan.
Randomised feasibility study outcomes
The outcomes will be collected in a variety of ways. Demo-
graphic data will be collected from patients and their re-
cords. Recruitment rates will be collected by researchersfrom their screening and recruitment records. At base-
line and 3 months follow-up, patient-completed outcome
measures will be completed by participants, assisted by
NISCHR CRC professionals or a member of the research
team who will be blind to treatment allocation. Participants
will also be given the choice to complete validated versions
in Welsh where they exist. At baseline, fewer patient-
completed outcome measures will be used than at 3-month
follow-up as we wish to reduce the burden on patients at a
time shortly after surgery. Physical function will be object-
ively assessed by the researcher at baseline using the grip
strength test. At 3 months follow up, a physiotherapist will
measure other objective tests of physical function, including
the grip strength test. These will be performed in the
physiotherapy gym or if the patient is unable to travel in
their own home. The timing of outcome assessments is
summarised in Table 1.
Routinely collected demographic, clinical and recruitment
data
During recruitment to the feasibility study, we will col-
lect information on the number of patients approached,
the number eligible, the number who did and did not
consent, and where possible the reasons why. The num-
ber of eligible patients who fulfilled the inclusion criteria
Table 1 FEMuR protocol schedule of forms and procedures
Event Baseline Timeline post randomisation
During 3 months At 3 months Post 3-month follow-up
Eligibility screening and consent for randomised feasibility study
Patient X
Carer X
Outcome measurement for feasibility study
Cognitive status
•AMTS [25] X
Primary
•Barthel index [27] X X
Secondary
•NEADL Scale [28] X X
•HADS [29] X X
Process
•VAS for hip pain [30] X X
•GSES [32] X X
•FES-I [33,34] X
•SES [35] X
•VAS-FoF [36] X
Health economic
•EQ-5D 3L [37] X X
•ICECAP-O [38,39] X X
•CSRI [40] X X
•DCE [43] X
Physical
•Grip strength [45] X X
•30-s sit-to-stand [46,47] X
•8-ft (2.5 m) get-up-and-go [47] X
•50-ft (15.4 m) walk [48] X
Carer strain index X X
Therapist process outcomes and use of the intervention workbook
•Date of extra session X
•Whether the session is face to face or indirect X
•Where the face to face session is held X
•If the session is face to face, time is spent on assessment, exercise, ADL
practice, working on the workbook etc.
X
Qualitative follow up patients and carers focus groups/individual interviews - (invited)
Patients X X
Carers X X
Recruitment and consent of staff to focus groups X X X
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percentage of the numbers in the cohort dataset. In
addition, we will record the number who withdraw after
baseline assessment and randomisation, and the number
who complete the various outcome measures at baselineand 3 months follow-up. The researchers who adminis-
ter the outcome measures will record the reasons for
any non-completion.
The following demographic data and descriptors will
be collected:
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 Gender
 Type of fracture
 Type of surgery
 Living arrangements
 Place of residence prior to admission
 Place of discharge from acute and/or community
hospital
Cognitive status
 Abbreviated Mental Test Score (AMTS) [25].
The AMTS is a test with evidence of validity that is
widely used in clinical and research settings in the UK
for detecting and monitoring cognitive impairment. This
will be used as a baseline description of the level of cog-
nition. It is brief (ten items) and recommended for cog-
nitive screening in acute settings in the Alzheimer’s
Society (2013) tool-kit [26] ‘Helping you to assess cogni-
tion: a practical toolkit for clinicians’. It is generally con-
sidered to be easily administered and well tolerated by
raters and subjects. The score range is 0 to 10 with
higher scores indicating worse cognitive function.
Patient completed measures - primary outcome
 Barthel index [27].
This is a patient- or assessor-completed outcome meas-
ure of current functional status measuring individuals’
ability to care for themselves. It has evidence of validity
when used in patients with musculoskeletal or neuromus-
cular disorders and is considered easy to use, reliable and
sensitive to change. It focuses on the person’s level of in-
dependence on the following items: feeding, bathing,
grooming, dressing, bowel function, bladder function, toi-
let use, transfers, mobility on level surfaces and stairs. It
will be measured at baseline and at the 3-month follow-up
assessment. The score range is 0 to 20 with lower scores
indicating increased disability.
Patient completed measures - secondary outcomes
 Nottingham Extended Activities of Daily Living
(NEADL) Scale [28].
This is a patient-completed outcome measure of activ-
ities of daily living from the previous 4 weeks which has
evidence of validity in stroke patients. The NEADL is a
record of actual activity rather than capability, scoring pa-
tients in the areas of mobility, kitchen, domestic and leis-
ure activities. A higher score indicates a greater level of
independence. When assessed at baseline, it will assess theparticipant’s functional capacity prior to hip fracture. It will
also be used at the 3-month follow-up assessment to assess
the degree of functional recovery. The score range is 0 to
66 with higher scores indicating greater independence.
 Hospital Anxiety and Depression Scale (HADS) [29].
This is a patient-completed outcome measure of anx-
iety and depression. It is designed to measure anxiety
and depression in patients with physical health prob-
lems. It has seven items related to common symptoms
of anxiety and seven for depression. Patients are asked
whether they experience the symptom definitely, some-
times, not much or not at all. The HADS was designed
for use in the hospital setting but has been used suc-
cessfully with the general population. This measure
will be used at baseline and at the 3-month follow-up
assessment. The two sub-scales have a range of 0 to
21 with higher scores indicating increased anxiety or
depression.
Process measures (potential mediators of outcomes)
 Visual Analogue Scale (VAS) for hip pain inten-
sity [30].
This is a patient-completed visual analogue scale of
current hip pain intensity. Hip pain following surgery is
an important factor affecting rehabilitation and will be
measured at baseline and at the 3-month follow-up as-
sessment. We have chosen a VAS as there is evidence of
validity compared with the Oxford Hip Score [31] whilst
being simpler and quicker to complete, thus reducing
the burden on patients. The range is 0 to 10 on a seg-
mented line.
 General Self-Efficacy Scale (GSES) [32].
The GSES is not behaviour specific and is chosen as a
measure of general confidence when facing challenge. In
order to assess change over time in such expectancy-
based cognitions pre and post intervention (as well as test
between group differences at follow-up comparing inter-
vention with control), we have chosen this short self-
efficacy scale for baseline. It has evidence of validity in the
populations of older people and surgical patients. The
range is 10 to 40 with higher scores indicating increased
self-efficacy. The measure will also be completed at 3-
month follow-up with the more behaviour specific Falls
Efficacy Scale - International and the self-efficacy for exer-
cise scale (see below).
 Falls Efficacy Scale - International (FES-I) (self effi-
cacy) [33,34].
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falling when performing activities of daily living both
inside and outside of the home. The scale details 16 ac-
tivities which the patient must rate from 1 (not at all
concerned) to 4 (very concerned) with regards to how
concerned they would be about falling if they performed
the activity. The range is 16 to 64 with higher scores in-
dicating a greater fear of falling. The FES-I has been
used successfully in older patients both without and with
mild cognitive impairment.
 Self-efficacy for exercise scale [35].
The self-efficacy for exercise scale is a revision of un-
published self-efficacy barriers to exercise measure. The
scale consists of statements regarding the participant’s
confidence that they could exercise for 20 min, three times
a week, depending on factors such as pain and mood. The
participants are instructed to use numbers from 0 (not
confident) to 10 (very confident) to rate their expectations.
This measure assesses the participant’s present expecta-
tions and so will be used only at the 3-month follow-up
as pain from surgery would likely be the major factor in
these expectations at baseline and would not measure
normal levels of self-efficacy for the patient. The range
is 0 to 90 with higher scores reflecting more confidence
in capability.
 Visual Analogue Score - Fear of Falling (VAS-
FoF) [36].
This is a patient-completed visual analogue scale for
fear of falling. A VAS is useful as it is easy to administer
and brief. The range is 0 to 10 on a segmented line with
higher scores indicating greater fear of falling. It has pre-
viously been used in older adults with and without cog-
nitive impairment with good results [25] and will be
used to measure fear of falling in our study at 3 months
follow-up.
Health economic measures
 EuroQol EQ-5D (three levels) [37].
This is a patient-completed index of health-related
quality of life, which gives a weight to different health
states. It consists of five dimensions: mobility, self-care,
usual activities, pain/discomfort, and anxiety/depression.
Each has three possible responses. The responses record
three levels of severity (no problems, some/moderate
problems and extreme problems) which is then con-
verted to a health utility weight using UK norms. It will
be used at baseline and at the 3-month follow-up assess-
ment and allows the calculation of quality-adjusted lifeyears (QALYs), using area under the curve method
which will be used as part of the economic analysis.
 ICEpop CAPability measure for Older people
[38,39].
This is a patient-completed measure of capability in
older people that focuses on well-being rather than
health. It comprises five attributes: attachment (love and
friendship); security (thinking about the future without
concern); role (doing things that make you feel valued);
enjoyment (enjoyment and pleasure); and control (inde-
pendence). Each attribute has four possible responses.
The responses record the extent of capability (all, a lot, a
little, and none), and the five-digit outcome is converted
to capability utility derived from UK norms. It will be
used at baseline and at the 3-month follow-up assess-
ment as part of the economic analysis.
 Client service receipt inventory (CSRI) [40].
The CSRI is a questionnaire for collecting retrospective
information about study participants’ use of health and so-
cial care services, including voluntary services (e.g. charity
services), including the components of the rehabilitation
programme. This information will be combined with na-
tional sources of reference unit costs [41,42] in order to
calculate health and social care service costs for the eco-
nomic evaluation. It will be used at baseline and at the
3-month follow-up assessment as part of the economic
analysis.
 Discrete choice experiment [43,44].
A discrete choice experiment (DCE) [43,44] will ex-
plore participants’ preferences for rehabilitation services.
Hypothetical rehabilitation services (A and B) will be
presented to each participant according to a set number
of characteristics, each of which has different levels.
These characteristics and levels will create a set of alter-
native scenarios. In each scenario, the participant will be
asked which service they prefer by ticking ‘A’ or ‘B’. The
characteristics and levels will be chosen for the DCE
based upon the outcomes of the literature review and
focus groups conducted in phase I of the study. It will
be used at the 3-month follow-up assessment as part of
the economic analysis.
Objective measures of physical function
 Grip strength [45].
This is an objective measure of physical function that
will be administered by the researcher administering the
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well with general fitness and muscle strength relating to
physical function. It is also a more appropriate measure for
use at baseline, as performing other physical assessments
may carry risk to patients at this time point or would be
likely to primarily reflect post-operative pain and not over-
all function. Grip strength will be measured at baseline and
at the 3-month follow-up assessment. Other objective
measures will be administered by a physiotherapist at the
3-month follow-up and are listed below:
 Thirty-second sit-to-stand [46,47].
From a seated position in a chair with no armrests, the
participant rises to a full stand and returns to a fully
seated position without using their arms to support them-
selves. An observer measures the number of stands com-
pleted in 30 s. The 30-s sit-to-stand is used to measure
lower body strength and is useful in older adults because
it is part of everyday activities, e.g. getting off the toilet
and getting in and out of a car and a chair. It correlates
reasonably well with other measures of lower body
strength such as knee extensor and knee flexor strength
and has been shown to have good test-re-test reliability in
older adults living in a community setting [46,47].
 Eight-foot (2.5 m) get-up-and-go test [47].
Timed up-and-go test (also known as ‘8 get-up-and-go’)
is used to assess mobility, agility and balance. An observer
measures the time taken for a participant to stand up from
a chair, walk 8 ft (2.5 m) with or without a walking aid,
turn 180°, walk back to the chair and sit down. There is
evidence of validity and reliability [33-36].
 Fifty-feet (15.4 m) walk test [48].
The participant is brought to start on a level 50-ft
(15.4 m) walk test course (25 ft out and 25 ft back) and
is asked on the command ‘go’ to walk as quickly as pos-
sible to the 25-ft (7.7 m) mark and back. An observer re-
cords the amount of time taken from the command ‘go’
until the starting line is crossed on the way back. It has
been shown that there are correlations between the re-
corded gait time and muscle strength and also with the
ability of older people living in the community to carry
out activities of daily living [49].
Carer completed measure - secondary outcome
 Caregiver strain index [18].
Carers who have been recruited onto the study will be
asked to complete this measure. It is a 13-item tool thatmeasures strain related to care provision. There is at
least one item for each of the following major domains:
employment, financial, physical, social and time. Positive
responses to seven or more items indicate a greater level
of strain. It can be used to assess individuals of any age
who have assumed the role of caregiver for an older
adult. It will be completed at baseline and at the 3
months follow-up. The range is 0 to 13 with a higher
score indicating greater strain.
Therapist process outcomes and use of the intervention
workbook
In order to describe the rehabilitation programme in
both arms of the feasibility study, we will access rou-
tinely collected data that therapists complete on their
‘Therapy Manager System’. An information technology
manager at BCUHB will extract the following data and
return them anonymously to the research team, identifi-
able only by participants’ study ID. The intervention
therapy teams will complete a paper record of how they
use the extra sessions which also form part of patients’
clinical records. A BCUHB member of staff will extract
the following from these records and return it to the re-
search team:
 Patient study identification, date of extra session;
 Whether the session is face to face or indirect;
 Where the face-to-face session is held; and
 If the session is face to face, how much time is spent
on different aspects such as assessment, exercise,
activity of daily living (ADL) practice and working
on the workbook.
We will assess whether the fidelity and dose of the en-
hanced rehabilitation programme delivered to partici-
pants is consistent with our programme theory. We will
describe how the programme is delivered along with
patients’ views and their use of the workbook which will
be collected through focus groups described later. The
workbook contains a page of questions and Likert scale
type response options to encourage participants to pro-
vide feedback on their workbook. Researchers will also
collect the diary sections to assess how they are used.
We will evaluate engagement with the workbook by
counting how many diaries are used, how regularly they
are filled out, and whether goals are set and quizzes
completed.
Triangulation study of service use information
The health service use data obtained from the patient
completed CSRI questionnaires will be compared with
the same information obtained from routinely collected
data recorded on computerised patient records. The data
will be collected by NWORTH and BCUHB IT staff.
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Recording adverse events
All adverse events will be recorded in this study. There
are adverse events (AEs) and serious adverse events
(SAEs). Adverse events will include the following:
 Non-injurious falls;
 An exacerbation of a pre-existing illness;
 An increase in frequency or intensity of a pre-
existing episodic condition;
 A condition (even though it may have been present
prior to the start of the feasibility study) detected
after the start of the study; and
 Continuous persistent disease or symptoms present
at baseline that worsens during the study.
The following will not be included as adverse events:
 Medical or surgical procedures where the condition
which leads to the procedure is the adverse event;
 Pre-existing disease or conditions present before
treatment that do not worsen; and
 Overdose of medication without signs or symptoms.
SAE will be any medical event that:
 Results in death;
 Is life-threatening (refers to an event during which
the participant was at risk of death at the time of
the event; it does not refer to an event which might
have caused death had it been more severe in
nature);
 Falls and repeat fractures;
 Requires hospitalisation or prolongation of existing
hospitalisation;
 Results in persistent/significant disability or
incapacity; and
 Other important medical events that, based upon
appropriate medical judgement, may jeopardise the
participant and may require medical or surgical
intervention.
Process for recording adverse events
All adverse events will be recorded by researchers when
they are made aware of the event by the patient, carer,
the treating clinicians, or therapists. Adverse event report-
ing information will be included in the training given to
the therapy teams delivering the intervention and they will
be given copies of the adverse event reporting forms
(Additional file 3) and details of how to return them to
the research team. Details of the adverse event reporting
procedure will also be included in letters to the partici-
pants’ GP and consultant informing them of their partici-
pation in the study. The adverse event form will have twosections, the first is for the healthcare professional to
complete and return to the study manager. The study
manager will liaise with the chief investigator who will de-
termine whether the adverse event is serious or not and
whether it is related to the study. The chief investigator
will complete the second part of the form. All serious ad-
verse events, along with the chief investigator’s assessment
of whether it is related to the study, will be sent to the
Data Monitoring and Ethics Committee (DMEC) for a
second opinion. The trial study manager will record the
information on the study master file and inform the clin-
ical trials unit manager. Study-related serious adverse
events will be reported to the sponsor and to the academic
school (Schools of Medical and Healthcare Sciences, Col-
lege of Health and Behavioural Science) within 24 h of be-
ing determined as serious. They will also be reported to
the DMEC chair and the research ethics committee.
Referral of vulnerable adults to protection agencies
(protection of vulnerable adults referral)
Staff and researchers recruiting patients have been provided
with statutory protection of vulnerable adults (POVA)
training by the BCUHB within vulnerable adult protection
framework [50] in accordance with Welsh Government
guidance [51,52]. A mechanism of immediate risk assess-
ment and onward referral to appropriate local authorities,
police and BCUHB POVA hub has been developed within
the framework of the Human Rights Act 1998 [53] and
Data Protection Act 1998 [54] if abuse or neglect is sus-
pected, observed or disclosed by the participants.
Statistics
Sample size We estimate that we will recruit 25% of eli-
gible patients with a proximal femoral fracture admitted
to the three acute hospitals in BCUHB and randomise
them to either the enhanced rehabilitation programme or
usual care. In order to estimate the standard deviation of
the primary outcome measure (Barthel index), which will
be used in a power calculation for a future definitive RCT,
with a high level of confidence a sample size of at least 50
participants completing the trial is advisable [55].
Statistical analysis
The main outcomes of the feasibility study will be the
descriptive statistics of recruitment and retention figures
as follows:
 The number of patients screened for eligibility;
 The number of eligible patients and a comparison
with the numbers in the cohort data set. A full trial
will be considered feasible if 50% of the patients
identified in the cohort study are eligible for
inclusion in the trial. Using the lower end of a 95%
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required to be eligible;
 Number of ineligible patients and frequency of
predetermined reasons for ineligibility (lack of
mental capacity to consent, not living independently,
living outside the study area, age, did not have
surgery for their hip fracture, living within the study
area but outside the area where the intervention
could be delivered, other);
 The number of eligible patients recruited (and so by
implication were willing to be randomised) will be
expressed as a percentage of the numbers in the
cohort data set and as a percentage of the numbers
identified as eligible in the feasibility study. The full
trial will be considered feasible if the expected 25%
of eligible patients are recruited to the trial, using
the 95% confidence interval this gives a minimum of
18% recruitment;
 The number of eligible patients not recruited and
the frequencies and reasons for this (e.g. burden, did
not want to be in a research study);
 The number who withdraw after baseline
assessment and randomisation and the reasons for
withdrawal; and
 The number who completed the various outcome
measurements at baseline and at 3-month follow-up.
The researchers who administer the outcome
measures will record the reasons for any non-
completion. The retention rate for the full trial to
be feasible is 75%, again using a 95% confidence
interval, this gives a minimum of 63% retention for
the full RCT to be plausible.
The following demographics descriptors will be pre-
sented overall and per randomised group:
 Date of birth (age)
 Gender
 Type of fracture
 Marital status and living arrangements
 Place of residence prior to admission
 Place of discharge from acute or community
hospital
 Abbreviated mental test score (AMTS)
All outcome measures will be presented descriptively
at all of the time points that they have been collected.
An exploratory correlation analysis will be performed.
Correlations will be calculated using Pearson’s product
moment correlation coefficient for specific pairs of vari-
ables as outlined below. All of the correlations will be
completed at both baseline and 3-month follow-up.
 Barthel index versus 8-ft get-up-and-go test.This is exploring the relationship between the patient’s
current functional status and the physical function test
used to assess their agility and dynamic balance.
 Barthel index versus general self-efficacy scale/falls
efficacy scale-international/self-efficacy for exercise
scale.
There are three different self-efficacy measures that
are being used within the feasibility stage of this study.
All three of these will be correlated with the primary
outcome measure to evaluate any differences between
them and assist in the decision as to which measure to
take forward to a full trial. The correlation is aiming to
compare the patient’s self-efficacy with their current
functional status to see if a link is present.
Preliminary exploratory analysis of the primary out-
come measure (Barthel index) will be completed to find
estimates of the means, standard deviations and confi-
dence intervals for both of the treatment arms. These
values will also allow the sample size calculation for the
future RCT to be calculated. An exploration of any po-
tential differences between the two groups in relation to
the Barthel index will be completed using a t-test. The
effect size and confidence intervals will also be calcu-
lated to inform a sample size calculation for a future
definitive RCT. It is envisaged that a more complex ana-
lysis would be required to elicit an accurate description
of the group differences; however, this would only be
possible with a larger sample size.
The secondary outcome measures, which are the
remaining outcomes at participant level, will follow the
same procedure as for the primary outcome measure de-
tailed above, as will the analysis for the only measure
taken in relation to the carers (caregiver strain index).
The results and appropriateness of the outcomes will be
evaluated for continuation for a future RCT.
Economic analysis
The enhanced rehabilitation programme will be fully
costed using unit costs from a public sector multiagency
perspective. Unit costs will be obtained from national
sources of reference costs [41,42] and applied to infor-
mation received from pilot questionnaires, namely salary
band of therapists, time spent with the patient conducting
rehabilitation, costs of travel and costs of any additional
equipment. Costs of health and social care services used
by the participants will also be costed using national
sources of reference costs. The costs of service use and
the cost of the intervention will be added together for use
in a cost-effectiveness analysis.
The EQ-5D (3L) will be used to calculate QALYs over
the 3-month study period, using area under the curve
method [56,57]. An exploratory cost-utility analysis will
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hanced rehabilitation intervention. This cost per QALY
generated will be compared to the NICE threshold range
of £20,000 to £30,000 per QALY [58]. If a treatment/
intervention costs more than £20,000 to £30,000 per
QALY, then it would not be considered cost effective.
The ICEpop CAPability measure for Older people
(ICECAP-O) [59] will be used to calculate a capability
index score. An exploratory cost-effectiveness analysis
will be conducted to calculate a cost per unit change in
ICECAP-O score. We will compare the use of these two
approaches, cost-utility analysis using QALYs and cost-
effectiveness analysis using ICECAP-O, as a capability
measure. We will explore the extent to which they can
help guide commissioning decisions following a full trial
and full economic evaluation.
The FEMuR feasibility study includes a discrete choice
experiment [43,44] to look at the participant’s prefer-
ences for the ‘process’ of exercise programmes. The
discrete choice experiment will assess which attributes
are important to participants and will be administered at
the 3-month follow-up. Based upon the data received
from the feasibility study, we will assess whether the use
of a discrete choice experiment is possible from a full
scale RCT of the FEMuR multidisciplinary rehabilitation.
Finally, we will scope out the potential of conducting a
social return on investment (SROI) analysis based on the
data obtained from the feasibility study to inform whether
a full SROI analysis is possible from a full-scale RCT
of the FEMuR multidisciplinary rehabilitation inter-
vention [60].
Triangulation study analysis
We will compare data collected directly from the partici-
pants with that obtained from routinely collected data
recorded on computerised patient records. There are
discrete variables such as number of GP visits, number
of hospital visits etc. as well as continuous variables such
as medication and associated costs that will be com-
pared for consistency. This comparison will be com-
pleted using the intraclass correlation coefficient (ICC)
with a value of above 0.7 showing good consistency be-
tween the two data sources.
Focus groups to assess the intervention
The acceptability and feasibility of the different compo-
nents of this new intervention, including its delivery and
the acceptability of being in a randomised study, will be
assessed in six focus groups. Three focus groups (n = 6 to
8) will be carried out with members of the multidisciplin-
ary rehabilitation teams. Focus groups will be based in
each of the three main hospital sites across BCUHB. We
will purposively sample a multidisciplinary group of staff
who have been involved with delivering the interventionor come into contact with patients involved in the inter-
vention. These staff will include physiotherapists, occupa-
tional therapists and their assistant staff and may also
include orthogeriatricians, nurses and social workers
based in community teams and on the hospital wards. In
addition, three focus groups of hip fracture patients
and their carers (n = 6 to 8) who participated in the en-
hanced rehabilitation programme intervention will be
convened.Patient focus group participants
All patient participants with capacity and their carers
will be asked when initially consenting whether they also
agree to be invited to a focus group later in their recov-
ery. All those who agree, and who were randomised to
the intervention group, will be invited to participate in
focus groups. We aim to recruit approximately eight
participants to each of the focus groups and should
more than eight of those invited wish to attend, we will
purposively select [61] participants to cover a range of
experiences of rehabilitation. We will ask patients if they
would prefer to participate in the focus group through
English or Welsh. If enough participants request it, we
will run a completely Welsh group. Otherwise, we will
run one or more bilingual groups using simultaneous
translation to facilitate patient language choice. We will
offer patients who move into residential care the alterna-
tive of having a telephone or face to face interview. They
will be asked to reply within a week to indicate whether
they would be willing to take part or not. Researchers
will then contact them with details of date, time and lo-
cation of the focus group being held nearest to their
place of residence. Patients and carers who reply to the
invitation to the focus group interviews will be contacted
by a member of the study team by phone who will ex-
plain what will be involved and will go through the in-
formation sheet giving them an opportunity to ask
questions (similar to Additional file 2). If they still wish
to take part in the focus group, they will be given infor-
mation about when and where the most convenient one
for them is taking place.
At the focus group, participants will be given the oppor-
tunity to ask questions before being asked to sign the con-
sent form by a researcher. They will be asked to sign two
copies of the consent form: one copy for themselves and
one for the research team’s records (similar to Additional
file 3).
Our experience of running focus groups in phase I of
the study was that it is difficult for many patients to at-
tend, particularly those who move to residential care set-
tings. We will therefore offer those individuals an
alternative, such as a face-to-face or telephone interview
with a researcher.
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Managers of therapy services will be approached by re-
search staff to help identify staff (e.g. physiotherapists,
occupational therapists, nurses and social work staff )
who have worked with patients in the intervention arms.
Identified staff will be approached by e-mail, phone or
letter by study researchers to ask if they would be willing
to take part in a focus group and if they know of any
other colleagues with experience of the intervention that
the researcher could approach. Participants and contacts
from the phase I focus groups will be approached to find
out whether they have experience of the intervention
and whether they would be willing to take part or know
of colleagues who might be interested. Staff focus groups
will be run in English, but we will check they agree to
this and make other arrangements if requested.
Researchers will check that staff participants have re-
ceived and understood the PIS and will give them oppor-
tunity to ask questions about the study at the beginning
of the focus group.
Focus group procedures
We will have six to eight participants in each focus
group. All participants will give written consent to par-
ticipate and will agree that their comments can be re-
corded, transcribed and anonymised for analysis. The
discussions in the focus groups will be semi-structured
and run by a moderator and co-moderator, using a topic
guide. The topic guide will be modified in an iterative
fashion after each focus group. The topic guide will con-
tain open-ended questions regarding hip fracture pa-
tients and their carers’ experiences, perceptions and
beliefs about the new rehabilitation programme. Topics
covered will be informed by the aims and objectives of
the study and the intervention logic model. The discus-
sion will be digitally recorded.
Qualitative data analysis
Transcripts of the focus groups will be analysed using
the framework approach to thematic analysis [62]. A
framework will be developed based on the programme
theories, logic model and the questions of feasibility and
acceptability this study is designed to answer. The tran-
scripts will be coded and grouped together into categor-
ies by the researchers who will have conducted the focus
groups. These researchers will discuss, compare and
name the categories which will be used to populate and
refine the framework. Data that does not fit within the
existing framework will be used to develop new sections
of the framework that will be agreed amongst the re-
searchers. The framework will be used to develop
themes that contribute to answering the study’s feasibil-
ity and acceptability questions. Transcript coding and
categorising, development of the framework and themeswill be reviewed and discussed by the researcher leading
on analysis and other members of the team to ensure a
rigorous analysis process. This will include appropriate
methods for ensuring the findings are plausible and cred-
ible. A member of the research team, who has not been
involved in the categorising and populating of the frame-
work, will conduct a check of the framework and themes
by reviewing several transcripts and assessing whether the
coding, categorising and placement within the framework
is plausible and credible.
Trial management
Study management group
A study management group (SMG) consisting of individ-
uals responsible for the day-to-day running of the study
has been established and is responsible for overseeing the
progress of the study throughout all of its phases and
meets regularly every 1 to 2 months. The SMG includes
the chief investigator (NHW), study manager (CH), study
statistician (ZH), trial unit quality assurance manager and
study co-applicants. The group ensures that the protocol
is adhered to, takes appropriate action to safeguard partic-
ipants and ensure the overall quality of the study. The
SMG reports to the study steering committee (SSC) and
the DMEC.
Study steering committee
A SSC meeting is being held every 3 to 6 months in
order to provide overall supervision of the study and en-
sure that the study is conducted to the rigorous stan-
dards set out in the guidelines for good clinical practice.
The SSC consists of the following members: an inde-
pendent chair (Dr. Sharon Simpson), other independent
members (Dr. Fiona Wood, Dr. John Belcher, Prof George
Kernohan, Dr. Tom Welsh), patient representative (Ms.
Tricia Best), chief investigator (NHW), study manager
(CH), members observing from Bangor University as the
sponsoring organisation (BW), and a representative from
NISCHR-CRC (Mrs. Jayne Jones). It considers study pro-
gress and adherence to the protocol and provides advice
to the study team. The SSC will make recommendations
to the SMG and report to the sponsor and the funder.
Terms of reference for the SSC are available on request
from the FEMuR study office.
DMEC
Data monitoring and quality assurance is being overseen
by the DMEC. The DMEC is independent of the study
organisers. It considers study progress, recruitment and
retention, patient safety and any new information rele-
vant to the study. The DMEC consists of the following
members: an independent chair and statistician (Prof.
Chris Robertson) and other independent members who
are experts in the field of rehabilitation of older people
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Terms of reference for the DMEC are available on re-
quest from the FEMuR study office. The DMEC will re-
port to the SSC.
Ethics and regulatory approvals
NHS research ethics (13/WA/0402) and NHS research
and development approvals have been obtained. All trial
documentation, including participant information sheets,
participant consent forms, template GP letters, and ques-
tionnaires have been submitted for approval. To conform
to the Data Protection Act and Freedom of Information
Act, all data will be anonymised and stored securely.
No published material will contain patient identifying
information.
Direct access to source data/documents
Source data will be the hospital written and electronic
medical records and routinely collected data, community
electronic and written records, audio recordings and
transcripts of the focus group interviews. Access to this
data will be through members of NISCHR CRC, BCUHB
IT staff and researchers on the team who will have NHS
research passports. Trial-related monitoring, audits, Re-
search Ethics Committee reviews and regulatory ins-
pections will be permitted, allowing access to data and
documents where required.
Quality assurance and quality control
This study will be conducted in line with this study
protocol and will follow the principles of good clinical
practice outlined by the ICH-GCP [63] and will comply
with the EU directive 2001/20/EC [64].
Regular monitoring activities will be put in place based
on a study risk assessment and delegated to members of
the study team to ensure that collected data adhere to
the requirements of the protocol; only authorised per-
sons complete Case Report Forms (CRFs); the potential
for missing data is minimised; validation checks are per-
formed on the data (e.g. range and consistency checks);
and recruitment rates, withdrawals and losses to follow-
up are reviewed overall and by hospital site. Only mem-
bers of the research team who have completed GCP
training and have training in focus groups or are super-
vised by an experienced team member will conduct or
be co-moderator at these groups.
Data handling
Data capturing method Quantitative data for the feasi-
bility study will be entered into the MACRO data manage-
ment programme, which is a web-based system allowing
controlled access to data by all centres and stores a full
audit trail. Additional health service use data obtainedfrom primary and secondary care records will be recorded
electronically on encrypted laptop computers or collected
by NHS staff on secure computers and anonymised in an
electronic data set that is ready for secure transfer to
NWORTH.
Data from the focus group interviews will be digital
recordings of the focus group discussion and notes taken
during the focus groups by the moderator or co-moderator.
At the end of the focus group, the recording will be down-
loaded on to an encrypted NWORTH laptop and subse-
quently downloaded and stored on the university server in
a folder with access limited to core members of the study
team. Transfer of the recording to an approved transcriber
and return of the transcript will be done by encrypting the
recording and uploading to/downloading from a secure ser-
ver. Written notes will be taken taking care to not to record
personally identifiable data, and they will be stored in
locked cabinets in locked rooms in NWORTH accessible to
authorised team members only.Coding specifications
The design of the source documentation in MACRO will
be documented specifying the design, format, derivation
and validations used for each type of question in the
coding specification. The data captured will be stored in
a database running on servers maintained by Bangor
University. Access to the complete database will be lim-
ited to the core team members of the project involved in
data management, data cleaning, analysis and study
management. The physical storage of paper case report
forms will be documented within the data management
plan. The coding will be conducted in the design set-up
phase of the source documentation for MACRO. The
code book will be shared along with the data in the data
sharing process to allow meaningful interpretation of the
data set by other researchers in the project.Data transfer process steps
Data from the focus group notes and transcriptions of the
discussion will be transferred to NVIVO [65] or Excel™
software for qualitative analysis. Data from the feasibility
study on the MACRO data management programme will
be made available for analysis via SPSS 20.0 [66]. Paper
copies of case report forms (participant questionnaires)
will be stored securely on Bangor University premises dur-
ing the trial. Photocopies, if needed, will be made before
returning any originals to NWORTH. The originals will
be returned to NWORTH via recorded delivery/courier
for data entry, if necessary, and for archiving at the end
of the study. The photocopies held at the site will be
destroyed at the end of the trial once all the final data set
is closed. Consent forms wherever possible will be stored
securely at the NHS sites.
Williams et al. Pilot and Feasibility Studies  (2015) 1:13 Page 19 of 22Any consent forms (e.g. focus group consent forms)
and paper recorded data stored at Bangor University will
be kept in separate locked cabinets.
Review of the quantitative data
A periodic review of the data will be performed to ensure
accuracy of data entered into the database. The researchers
entering the data into online system will randomly check
each other’s entries against the paper CRFs to ensure
consistency and accuracy, determine if all participant data
has been entered and checked for missing values, and iden-
tify any obvious problems. A random check of ID, number
of entries and out-of-range values will be also performed.
Data management
A data management plan has been written which covers
processes for auditing, cleaning and monitoring quality.
The transcripts of the focus groups will be checked for
accuracy of transcript by one of the researchers who
attended the focus group and by using the audio record-
ing as necessary. The transcripts will be checked for any
identifying data such as names and places and these will
be removed or replaced with a description of what sort
of information it was so the transcript still makes sense
and to ensure anonymity of the participants.
Data sharing
Data will be shared with the members of the research
group when required. The member may formally request
for a specific data set using a data request form which is
included in the data management plan. All such requests
will need to be approved by the chief investigator
(NHW). All quantitative data will be accompanied by a
copy of the relevant codebook. The request and the data
set provided to which member will be recorded and
saved in respective folders named after the member.
Data archiving
Data archiving details the storage of the data after the
study has ended complete with the relevant audit trail
that will allow tracking from raw entered data to the
final master data set used for analysis. The storage loca-
tion of hard copy data will be recorded in the data man-
agement plan. At the end of the study original data,
analysis data and the data tracking file will be archived
with access only to authorised people.
Publication policy
Dissemination plan A publication strategy has been de-
veloped. We are committed to publishing in a wide range
of peer-reviewed journals in multiple disciplines, e.g. re-
habilitation medicine, physiotherapy, health psychology,
and to ensuring that appropriate recognition is given to allwho have worked on the study. We are also committed
to making research data accessible for secondary ana-
lysis. We will also disseminate the results to the teams
that look after patients with proximal femoral fracture
in Betsi Cadwaladr University Health Board, in the acute
hospitals, the community hospitals and the community re-
habilitation teams and at scientific meetings to primary and
community care, orthopaedic and rehabilitation audiences.
Authorship eligibility To qualify as an author, the au-
thor will have made substantial contributions to the con-
ception and design, or acquisition of data, or analysis and
interpretation of data; been involved in drafting the manu-
script or revising it critically for important intellectual
content; given final approval of the version to be published
with each author having participated sufficiently in the
work to take public responsibility for appropriate portions
of the content; and agreed to be accountable for all as-
pects of the work in ensuring that questions related to the
accuracy or integrity of any part of the work are appropri-
ately investigated and resolved [67].
Indemnity
Bangor University has appropriate Clinical Trials Indem-
nity and Professional Indemnity insurance in place that
will cover members of the research team to conduct the
research as per protocol. NISCHR CRC staff has NHS
contracts and will be responsible to ensure that their work
is appropriately insured. NHS and social services staff who
work with patients involved in the intervention will not be
expected to do anything that is not covered by their con-
tracts and will remain covered by the NHS or social ser-
vices insurance arrangements.
Discussion
The enhanced multidisciplinary rehabilitation programme
has been developed from programme theories obtained
from a realist review of the hip fracture rehabilitation lit-
erature, with contributions from a survey of current prac-
tice and focus groups of patients, carers and rehabilitation
team members. In this randomised feasibility study, we
will use mixed methods to examine different aspects of
this programme: its acceptability in focus groups; quality
of life, functional ability, mental health, potential psycho-
logical mediators of outcome and health service use with
patient completed outcome measures; objective measures
of physical function; patients’ preference for the content
of the programme in a discrete choice experiment; rou-
tinely collected information to measure health service use
and process outcomes; and adverse event reporting. The
criteria for judging the feasibility of a future RCT will be
an eligibility rate of greater than 50% of those screened
(lower bound of a 95% confidence interval (CI) would be
44%), recruitment rate greater than 25% of those eligible
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3-month follow-up greater than 75% (lower bound of a
95% CI would be 63%).
Phase II studies are primarily intended to test the
feasibility and acceptability of the various trial methods
prior to a larger definitive phase III randomised con-
trolled trial. However, they also provide an opportunity
to compare and contrast different methods such as
patient-completed questionnaires with objective mea-
sures of physical function; collecting health resource
data from routinely collected information with patients’
self-report; different process and outcome measures for
self-efficacy, functional ability and quality of life; and dif-
ferent objective measures of physical function.
We have also described how we envisage our complex
rehabilitation intervention works in a logic model whose
starting point was the programme theories [15], through
to short-term and long-term goals, and finally, how
these influence an individual’s impairments, activity and
participation according to World Health Organisation’s
ICF model [24]. Some of the process outcomes to be mea-
sured can be used to start to explore this model such as
the three measures of self-efficacy and participants’ en-
gagement with the personal goal setting set out in the
workbook and goal-setting diary. Rehabilitation therapy
self-efficacy has been shown to be associated with func-
tional recovery in a small US cohort study [23] and also
from a systematic review in the related field of joint re-
placement surgery [8]. The logic model will also be used
to inform the framework developed for qualitative data
analysis. This will add to its evaluation and also potentially
provide valuable data on how to refine the model and the
intervention for a future definitive RCT.
Trial sponsor
Bangor University: sponsor’s reference 11/33/03.
Contact: Professor Bob Woods, Schools of Healthcare
and Medical Sciences, Ardudwy, Normal Site, Holyhead
Road, Bangor, LL57 2AS. Tel: (01248) 383719. Fax: (01248)
382229.
Ethical approval
Ethical approval was obtained from the North Wales
West Research Ethics Committee (REC reference 13/
WA/0402).
Trial status
The randomised feasibility study has research ethics and
R&D approval and has started to recruit participants.
Additional files
Additional file 1: Participant information sheet: patient.Additional file 2: Fracture in the Elderly Multidisciplinary
Rehabilitation (FEMuR) study.
Additional file 3: Adverse event reporting.
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